Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Zepbound copycats remain online despite FDA ban

March 21, 2025

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

March 11, 2025

5 things to know before the stock market opens Monday

March 10, 2025

Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug

March 10, 2025

Amgen starts two critical late-stage trials for weight loss drug MariTide

March 05, 2025

Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

March 05, 2025

Healthy Returns: AbbVie is the newest potential weight loss drug market player

March 04, 2025

Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

February 26, 2025

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

February 21, 2025

Cramer's Lightning Round: Sunoco is a buy

February 20, 2025

Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s

February 19, 2025

Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest

February 13, 2025

Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

February 10, 2025

Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad

February 07, 2025

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

February 06, 2025

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

February 05, 2025

Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter

February 05, 2025

Healthy Returns: Why people quit weight loss, diabetes drugs within one year

February 04, 2025

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

January 31, 2025

FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use

January 28, 2025

World's largest luxury group LVMH posts better than feared full-year sales

January 28, 2025

Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses

January 28, 2025

Novo Nordisk shares pop 10% on early-stage weight loss drug trial results

January 24, 2025

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

January 21, 2025

'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says

January 21, 2025

GLP-1s and Brian Thompson’s killing loom large at top health-care conference

January 18, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

Eli Lilly CEO expects new weight loss pill to be approved next year

January 13, 2025

High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups

January 10, 2025

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says

January 08, 2025

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.